Interactions médicamenteuses
Brexucabtagene autoleucel + Pralatrexate
Gravité: Majeure
Brexucabtagene autoleucel and Pralatrexate: major interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Pralatrexate is a myelosuppressive antifolate that can impair the expansion and function of CAR T cells and add to infection risk. Chemotherapy around the time of CAR T infusion can reduce the efficacy of the cell product and worsen cytopenias.
Ce que signifie cette interaction, en termes simples
Brexucabtagene autoleucel and Pralatrexate can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Pralatrexate belongs to Oncology.
Pourquoi elle survient
Cytotoxic and myelosuppressive effects of pralatrexate may reduce CAR T-cell persistence and add to immunosuppression.
Conduite à tenir
Avoid pralatrexate around leukapheresis and in the period after CAR T infusion unless clearly needed. Monitor blood counts and screen for infection.
Questions à poser à votre pharmacien
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Brexucabtagene autoleucel et Pralatrexate, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Pralatrexate
- Adenovirus types 4 and 7 live + Pralatrexate Contre-indiquée
- Axicabtagene ciloleucel + Pralatrexate Majeure
- Ciltacabtagene autoleucel + Pralatrexate Majeure
- Dengue vaccine + Pralatrexate Majeure
- Diflunisal + Pralatrexate Majeure
- Etrasimod + Pralatrexate Majeure
Autres interactions de Brexucabtagene autoleucel
Questions fréquentes
Can I take Brexucabtagene autoleucel with Pralatrexate?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Pralatrexate can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pralatrexate is a myelosuppressive antifolate that can impair the expansion and function of CAR T cells and add to infection risk. Chemotherapy around the time of CAR T infusion can reduce the efficacy of the cell product and worsen cytopenias.
How serious is the interaction between Brexucabtagene autoleucel and Pralatrexate?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid pralatrexate around leukapheresis and in the period after CAR T infusion unless clearly needed. Monitor blood counts and screen for infection.
What other medicines interact with Pralatrexate?
MediHelp also lists interactions of Pralatrexate with, for example, Adenovirus types 4 and 7 live, Axicabtagene ciloleucel, Ciltacabtagene autoleucel. The full list is on the Pralatrexate page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
